Poland’s health technology (healthtech) sector is entering a new phase of maturity, driven by rising healthcare demands, an increasingly digital population, and government initiatives to modernize public health infrastructure.

Startups are addressing pressing challenges, such as long waiting times, rural access gaps, and the growing burden of chronic diseases, through telemedicine, artificial intelligence, and digital diagnostics. At the same time, investors are recognizing the country’s scale and strategic position within the EU as an attractive platform for regional expansion.

This article explores Poland’s evolving healthtech ecosystem, emerging technological trends, regulatory considerations, and the opportunities awaiting foreign and domestic investors.

Market Landscape

A Market Ripe for Digital Transformation

Poland’s healthcare system, anchored by the National Health Fund (NFZ), serves nearly 38 million residents, but faces structural challenges common across Europe: overstretched hospitals, a shortage of medical professionals, and uneven access to care in rural regions.

These pressures have created strong incentives for digital innovation, with entrepreneurs and research institutions developing solutions that enhance efficiency, improve outcomes, and empower patients to manage their health.

According to EU data, Poland’s healthcare expenditure exceeds 6% of GDP, and the government continues to prioritize digital transformation through programs such as e-Health (P1) and the Digital Poland Operational Program, both co-funded by the European Union.

The convergence of healthcare, data analytics, and software development, combined with Poland’s deep engineering talent pool, has positioned the country as one of Central Europe’s most promising healthtech frontiers.

Emerging Trends in Polish HealthTech

  1. Telemedicine and Remote Diagnostics The COVID-19 pandemic accelerated telemedicine adoption, and it remains a core component of healthcare delivery. Platforms offering video consultations, e-prescriptions, and digital triage have become widespread. Startups such as Telemedi.co and Infermedica provide scalable systems for remote diagnosis, while hospitals and insurers increasingly integrate telehealth services to reach patients in rural and underserved areas.
  2. AI-Driven Diagnostics and Predictive Analytics Artificial intelligence is enhancing clinical accuracy and efficiency. Polish innovators are building algorithms that analyze medical imaging, assist in early detection of diseases, and optimize hospital workflows. AI-supported diagnostic tools are being used for radiology, pathology, cardiology, and oncology, helping clinicians interpret data faster and reduce diagnostic errors. Infermedica’s AI-powered symptom checker, for example, is already deployed in over 30 countries.
  3. Medical Devices and Wearables Poland’s engineering base supports the development of portable diagnostic devices, biosensors, and health-tracking wearables that sync with smartphones or cloud platforms. Products range from glucose monitors and blood pressure sensors to remote cardiac monitoring devices. These innovations enable patients to track vital parameters and share data securely with healthcare providers, aligning with the global trend toward patient-centered care.
  4. Pharmaceutical Innovation and Biotech The boundary between healthtech and biotech continues to blur. Polish biotech firms and university spin-offs are researching novel drug delivery systems, biologics, and digital therapeutics. Collaborations between pharmaceutical companies and research institutions, such as Celon Pharma’s partnerships with academic labs, underscore Poland’s growing role in translational medicine.
  5. Digital Health Infrastructure and Interoperability To support innovation, the Polish government promotes the standardization of electronic medical records (EMR) and data interoperability. Integration between public and private healthcare providers is improving, opening opportunities for SaaS healthtech vendors to deliver analytics and patient management platforms.

Investment Climate

Growing Investor Interest

Poland’s technology investment landscape has surged in recent years. Venture capital funding reached €791 million in 2021 and €781 million in 2022, a portion of which flowed into medical startups. The healthtech segment, situated at the crossroads of software and healthcare, is increasingly attracting both technology VCs and strategic healthcare investors.

While fintech and SaaS remain Poland’s largest VC segments, healthtech offers a compelling mix of social impact and financial scalability, making it attractive to impact investors and funds with ESG mandates.

Several Polish funds, such as PFR Ventures, Innovation Nest, and SpeedUp Group, have launched healthcare-focused vehicles, often co-financed by EU instruments like Horizon Europe or the European Innovation Council (EIC).

Strategic Advantages for Foreign Investors

  1. EU Market Access – As an EU member, Poland provides direct access to 448 million consumers and seamless trade with other EU states.
  2. Cost Efficiency – Labor and operating costs remain lower than Western Europe’s, improving ROI for R&D and clinical operations.
  3. Talent Pool – Universities graduate thousands of engineers, data scientists, and biomedical specialists annually, supporting startups’ rapid scaling.
  4. Favorable Time Zone and Cultural Proximity – Convenient for companies managing operations across Europe and North America.

Regulatory Considerations

Poland’s regulatory framework aligns with EU standards but demands careful navigation.

  1. Medical Device Regulation (MDR) – All medical devices and digital therapeutics must comply with the EU MDR (2017/745), which governs safety, performance, and clinical evaluation. Startups developing apps or diagnostic devices must obtain CE marking before market entry.
  2. Data Protection and Privacy – Compliance with the General Data Protection Regulation (GDPR) is mandatory. Sensitive health data must be processed under strict security protocols, and cross-border transfers require appropriate safeguards.
  3. FDI Screening Regime – Foreign investors from outside the EU, EEA, or OECD acquiring stakes in Polish healthcare or biotech firms may be subject to FDI screening under national security provisions. Transactions involving critical public health infrastructure, such as vaccine manufacturing or digital health records, require prior government approval.
  4. Public Procurement Rules – Opportunities exist in supplying the National Health Fund (NFZ), hospitals, and regional authorities with digital solutions. However, public tenders require familiarity with the Public Procurement Law (PZP) and proof of interoperability with state systems.
  5. Tax Incentives – Healthtech firms benefit from several innovation-friendly mechanisms:

Opportunities and Challenges

Opportunities

  • Growing Demand for Digital Care: Patients increasingly expect digital access to consultations, prescriptions, and diagnostics.
  • EU and National Grants: Co-funding is available for pilot projects, research consortia, and technology adoption.
  • Cross-Border Scalability: Healthtech solutions developed in Poland can easily expand to other EU markets.
  • Corporate Partnerships: Hospitals and pharmaceutical companies are open to co-developing new tools, offering validation and clinical data.
  • Academic Collaboration: Universities offer access to research infrastructure and trial participants for clinical testing.

Challenges

  • Lengthy Certification Processes: Navigating MDR and data compliance can delay go-to-market timelines.
  • Fragmented Healthcare System: Integration across NFZ and private providers is still evolving.
  • Investor Education: Some traditional investors remain cautious about regulatory complexity.
  • Talent Competition: Demand for data scientists and regulatory experts exceeds supply.

Strategic Considerations for Market Entry

  1. Partner with Hospitals and Universities Engage early with academic hospitals and medical faculties to validate products, conduct clinical trials, and build credibility.
  2. Build Regulatory Expertise Establish relationships with notified bodies, legal advisors, and consultants familiar with EU MDR certification. Maintaining compliance readiness can shorten commercial timelines.
  3. Leverage Local Talent and Tech Ecosystems Poland’s startup hubs, Warsaw, Kraków, and Wrocław, offer access to skilled developers and investors. Consider locating R&D teams there while using Warsaw for corporate operations.
  4. Focus on Interoperability and Integration Design products that align with Poland’s e-Health architecture and data exchange standards. Seamless interoperability enhances adoption by healthcare institutions.
  5. Plan for EU Expansion Early Use Poland as a launchpad for broader European entry, ensuring documentation and certifications align with EU-wide standards from the outset.
  6. Engage in Public–Private Partnerships (PPP) Collaborate with municipalities or regional authorities on pilot programs improving digital healthcare access, particularly in underserved areas.

Example in Practice

A UK-based telemedicine startup seeking to expand into Central Europe partnered with a Polish university hospital to pilot its AI triage tool. Expand2Poland facilitated regulatory guidance and introduced the firm to a regional venture fund.

The result: within 18 months, the company secured CE certification, won its first NFZ procurement contract, and began exporting its Polish-developed platform to Germany and the Nordics.

Strategic Outlook

Poland’s healthtech sector stands at the intersection of medical need, digital innovation, and international investment. As the healthcare system embraces data-driven solutions, the market’s potential extends far beyond national borders.

With supportive policy frameworks, EU integration, and a technically skilled workforce, Poland is rapidly becoming Central Europe’s hub for medical innovation. Investors who engage now can help shape the future of accessible, intelligent healthcare across the continent.

How Expand2Poland Can Help

Expand2Poland supports medical technology innovators, investors, and corporates throughout their market journey.

We can help with:

  • Partner identification with hospitals, universities, and R&D centers.
  • Grant and incentive mapping across national and EU funding programs.
  • Investor introductions and due diligence support.
  • Market strategy and localization assistance for product launch and scale-up.

With our expertise, you can confidently enter and thrive in Poland’s healthtech ecosystem, while positioning your company for sustainable growth across the European healthcare market.

The information provided in this article is for general informational and educational purposes only and does not constitute legal, financial, or tax advise.